Neurogene Inc.
NGNE
$36.14
$0.511.43%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | 0.00 | 0.00 |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | 0.00 | 0.00 |
| Cost of Revenue | 88.38M | 82.28M | 74.89M | 69.72M | 68.77M |
| Gross Profit | -88.38M | -82.28M | -74.89M | -69.72M | -68.77M |
| SG&A Expenses | 32.85M | 28.36M | 28.32M | 27.60M | 26.93M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 121.23M | 110.64M | 103.21M | 97.32M | 95.70M |
| Operating Income | -121.23M | -110.64M | -103.21M | -97.32M | -95.70M |
| Income Before Tax | -111.11M | -98.64M | -90.35M | -85.13M | -84.39M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -111.11 | -98.64 | -90.35 | -85.13 | -84.39 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -111.11M | -98.64M | -90.35M | -85.13M | -84.39M |
| EBIT | -121.23M | -110.64M | -103.21M | -97.32M | -95.70M |
| EBITDA | -117.99M | -107.45M | -100.12M | -94.22M | -92.57M |
| EPS Basic | -5.03 | -4.54 | -4.23 | -4.12 | -4.32 |
| Normalized Basic EPS | -3.14 | -2.84 | -2.64 | -2.57 | -2.70 |
| EPS Diluted | -5.03 | -4.54 | -4.23 | -4.12 | -4.32 |
| Normalized Diluted EPS | -3.14 | -2.84 | -2.64 | -2.57 | -2.70 |
| Average Basic Shares Outstanding | 88.11M | 86.61M | 85.30M | 82.69M | 78.47M |
| Average Diluted Shares Outstanding | 88.11M | 86.61M | 85.30M | 82.69M | 78.47M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |